APO Research
Talk to an analyst

APO RESEARCH · REPORT

His-Tag Antibody

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global His-Tag Antibody Market Analysis and Forecast 2026-2032

19 December 2025190 pages

Choose your research edition.

Industry ResearchHis-Tag Antibody Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal His-Tag Antibody Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal His-Tag Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal His-Tag Antibody Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal His-Tag Antibody Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global His-Tag Antibody market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for His-Tag Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for His-Tag Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for His-Tag Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for His-Tag Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of His-Tag Antibody include Aviva Systems Biology, Bio X Cell, BioLegend, Cell Signaling Technology, Columbia Biosciences, GeneTex, Medimabs, NSJ Bioreagents and OriGene, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for His-Tag Antibody, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of His-Tag Antibody, also provides the revenue of main regions and countries. Of the upcoming market potential for His-Tag Antibody, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the His-Tag Antibody revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global His-Tag Antibody market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for His-Tag Antibody revenue, projected growth trends, production technology, application and end-user industry.

His-Tag Antibody Segment by Company

Aviva Systems Biology

Bio X Cell

BioLegend

Cell Signaling Technology

Columbia Biosciences

GeneTex

Medimabs

NSJ Bioreagents

OriGene

Proteintech

Santa Cruz Biotechnology

United States Biological

His-Tag Antibody Segment by Type

Polyclonal

Monoclonal

His-Tag Antibody Segment by Application

Immunofluorescence

Immunoprecipitation

Western Blot

Others

His-Tag Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global His-Tag Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of His-Tag Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of His-Tag Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of His-Tag Antibody in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of His-Tag Antibody company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, His-Tag Antibody revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global His-Tag Antibody Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Polyclonal Major Player Table 3. Monoclonal Major Player Table 4. Global His-Tag Antibody Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Immunofluorescence Major Player Table 6. Immunoprecipitation Major Player Table 7. Western Blot Major Player Table 8. Others Major Player Table 9. His-Tag Antibody Industry Trends Table 10. His-Tag Antibody Industry Drivers Table 11. His-Tag Antibody Industry Opportunities and Challenges Table 12. His-Tag Antibody Industry Restraints Table 13. Global His-Tag Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global His-Tag Antibody Market Size by Region (2021-2026) & (US$ Million) Table 15. Global His-Tag Antibody Market Share by Region (2021-2026) Table 16. Global His-Tag Antibody Market Size by Region (2027-2032) & (US$ Million) Table 17. Global His-Tag Antibody Market Share by Region (2027-2032) Table 18. Global His-Tag Antibody Revenue by Players (US$ Million) & (2021-2026) Table 19. Global His-Tag Antibody Revenue Market Share by Players (2021-2026) Table 20. Global His-Tag Antibody Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global His-Tag Antibody Key Players Headquarters & Area Served Table 22. Global His-Tag Antibody Players, Product Type & Application Table 23. Global His-Tag Antibody Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global His-Tag Antibody by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global His-Tag Antibody Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global His-Tag Antibody Revenue by Type (2021-2026) & (US$ Million) Table 28. Global His-Tag Antibody Revenue by Type (2027-2032) & (US$ Million) Table 29. Global His-Tag Antibody Revenue Market Share by Type (2021-2026) Table 30. Global His-Tag Antibody Revenue Market Share by Type (2027-2032) Table 31. Global His-Tag Antibody Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global His-Tag Antibody Revenue by Application (2021-2026) & (US$ Million) Table 33. Global His-Tag Antibody Revenue by Application (2027-2032) & (US$ Million) Table 34. Global His-Tag Antibody Revenue Market Share by Application (2021-2026) Table 35. Global His-Tag Antibody Revenue Market Share by Application (2027-2032) Table 36. Aviva Systems Biology Company Information Table 37. Aviva Systems Biology Business Overview Table 38. Aviva Systems Biology His-Tag Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Aviva Systems Biology His-Tag Antibody Product Portfolio Table 40. Aviva Systems Biology Recent Development Table 41. Bio X Cell Company Information Table 42. Bio X Cell Business Overview Table 43. Bio X Cell His-Tag Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Bio X Cell His-Tag Antibody Product Portfolio Table 45. Bio X Cell Recent Development Table 46. BioLegend Company Information Table 47. BioLegend Business Overview Table 48. BioLegend His-Tag Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. BioLegend His-Tag Antibody Product Portfolio Table 50. BioLegend Recent Development Table 51. Cell Signaling Technology Company Information Table 52. Cell Signaling Technology Business Overview Table 53. Cell Signaling Technology His-Tag Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Cell Signaling Technology His-Tag Antibody Product Portfolio Table 55. Cell Signaling Technology Recent Development Table 56. Columbia Biosciences Company Information Table 57. Columbia Biosciences Business Overview Table 58. Columbia Biosciences His-Tag Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Columbia Biosciences His-Tag Antibody Product Portfolio Table 60. Columbia Biosciences Recent Development Table 61. GeneTex Company Information Table 62. GeneTex Business Overview Table 63. GeneTex His-Tag Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. GeneTex His-Tag Antibody Product Portfolio Table 65. GeneTex Recent Development Table 66. Medimabs Company Information Table 67. Medimabs Business Overview Table 68. Medimabs His-Tag Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Medimabs His-Tag Antibody Product Portfolio Table 70. Medimabs Recent Development Table 71. NSJ Bioreagents Company Information Table 72. NSJ Bioreagents Business Overview Table 73. NSJ Bioreagents His-Tag Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. NSJ Bioreagents His-Tag Antibody Product Portfolio Table 75. NSJ Bioreagents Recent Development Table 76. OriGene Company Information Table 77. OriGene Business Overview Table 78. OriGene His-Tag Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. OriGene His-Tag Antibody Product Portfolio Table 80. OriGene Recent Development Table 81. Proteintech Company Information Table 82. Proteintech Business Overview Table 83. Proteintech His-Tag Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Proteintech His-Tag Antibody Product Portfolio Table 85. Proteintech Recent Development Table 86. Santa Cruz Biotechnology Company Information Table 87. Santa Cruz Biotechnology Business Overview Table 88. Santa Cruz Biotechnology His-Tag Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Santa Cruz Biotechnology His-Tag Antibody Product Portfolio Table 90. Santa Cruz Biotechnology Recent Development Table 91. United States Biological Company Information Table 92. United States Biological Business Overview Table 93. United States Biological His-Tag Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. United States Biological His-Tag Antibody Product Portfolio Table 95. United States Biological Recent Development Table 96. North America His-Tag Antibody Revenue by Type (2021-2026) & (US$ Million) Table 97. North America His-Tag Antibody Revenue by Type (2027-2032) & (US$ Million) Table 98. North America His-Tag Antibody Revenue by Application (2021-2026) & (US$ Million) Table 99. North America His-Tag Antibody Revenue by Application (2027-2032) & (US$ Million) Table 100. North America His-Tag Antibody Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America His-Tag Antibody Revenue by Country (2021-2026) & (US$ Million) Table 102. North America His-Tag Antibody Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe His-Tag Antibody Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe His-Tag Antibody Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe His-Tag Antibody Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe His-Tag Antibody Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe His-Tag Antibody Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe His-Tag Antibody Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe His-Tag Antibody Revenue by Country (US$ Million) & (2027-2032) Table 110. China His-Tag Antibody Revenue by Type (2021-2026) & (US$ Million) Table 111. China His-Tag Antibody Revenue by Type (2027-2032) & (US$ Million) Table 112. China His-Tag Antibody Revenue by Application (2021-2026) & (US$ Million) Table 113. China His-Tag Antibody Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia His-Tag Antibody Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia His-Tag Antibody Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia His-Tag Antibody Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia His-Tag Antibody Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia His-Tag Antibody Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia His-Tag Antibody Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia His-Tag Antibody Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA His-Tag Antibody Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA His-Tag Antibody Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA His-Tag Antibody Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA His-Tag Antibody Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA His-Tag Antibody Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA His-Tag Antibody Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA His-Tag Antibody Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. His-Tag Antibody Image Figure 2. Global His-Tag Antibody Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global His-Tag Antibody Market Size Share 2021 VS 2025 VS 2032 Figure 4. Polyclonal Image Figure 5. Monoclonal Image Figure 6. Global His-Tag Antibody Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global His-Tag Antibody Market Size Share 2021 VS 2025 VS 2032 Figure 8. Immunofluorescence Image Figure 9. Immunoprecipitation Image Figure 10. Western Blot Image Figure 11. Others Image Figure 12. Global His-Tag Antibody Market Size (US$ Million) & (2021-2032) Figure 13. Global His-Tag Antibody Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global His-Tag Antibody Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global His-Tag Antibody Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global His-Tag Antibody Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global His-Tag Antibody Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global His-Tag Antibody Revenue Market Share by Type (2021-2032) Figure 20. Global His-Tag Antibody Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global His-Tag Antibody Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global His-Tag Antibody Revenue Market Share by Application (2021-2032) Figure 23. North America His-Tag Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America His-Tag Antibody Revenue Share by Type (2021-2032) Figure 25. North America His-Tag Antibody Revenue Share by Application (2021-2032) Figure 26. North America His-Tag Antibody Revenue Share by Country (2021-2032) Figure 27. United States His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe His-Tag Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe His-Tag Antibody Revenue Share by Type (2021-2032) Figure 32. Europe His-Tag Antibody Revenue Share by Application (2021-2032) Figure 33. Europe His-Tag Antibody Revenue Share by Country (2021-2032) Figure 34. Germany His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China His-Tag Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China His-Tag Antibody Revenue Share by Type (2021-2032) Figure 44. China His-Tag Antibody Revenue Share by Application (2021-2032) Figure 45. Asia His-Tag Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia His-Tag Antibody Revenue Share by Type (2021-2032) Figure 47. Asia His-Tag Antibody Revenue Share by Application (2021-2032) Figure 48. Asia His-Tag Antibody Revenue Share by Region (2021-2032) Figure 49. Japan His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA His-Tag Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA His-Tag Antibody Revenue Share by Type (2021-2032) Figure 57. SAMEA His-Tag Antibody Revenue Share by Application (2021-2032) Figure 58. SAMEA His-Tag Antibody Revenue Share by Country (2021-2032) Figure 59. Brazil His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt His-Tag Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Polyclonal
  • Monoclonal
Applications
  • Immunofluorescence
  • Immunoprecipitation
  • Western Blot
  • Others
Companies covered
  • Aviva Systems Biology
  • Bio X Cell
  • BioLegend
  • Cell Signaling Technology
  • Columbia Biosciences
  • GeneTex
  • Medimabs
  • NSJ Bioreagents
  • OriGene
  • Proteintech
  • Santa Cruz Biotechnology
  • United States Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 His-Tag Antibody Market by Type
  3. 1.2.1 Global His-Tag Antibody Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Polyclonal
  5. 1.2.3 Monoclonal
  6. 1.3 His-Tag Antibody Market by Application
  7. 1.3.1 Global His-Tag Antibody Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Immunofluorescence
  9. 1.3.3 Immunoprecipitation
  10. 1.3.4 Western Blot
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 His-Tag Antibody Market Dynamics
  1. 2.1 His-Tag Antibody Industry Trends
  2. 2.2 His-Tag Antibody Industry Drivers
  3. 2.3 His-Tag Antibody Industry Opportunities and Challenges
  4. 2.4 His-Tag Antibody Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global His-Tag Antibody Market Perspective (2021-2032)
  2. 3.2 Global His-Tag Antibody Growth Trends by Region
  3. 3.2.1 Global His-Tag Antibody Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global His-Tag Antibody Market Size by Region (2021-2026)
  5. 3.2.3 Global His-Tag Antibody Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global His-Tag Antibody Revenue by Players
  2. 4.1.1 Global His-Tag Antibody Revenue by Players (2021-2026)
  3. 4.1.2 Global His-Tag Antibody Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global His-Tag Antibody Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global His-Tag Antibody Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global His-Tag Antibody Key Players Headquarters & Area Served
  7. 4.4 Global His-Tag Antibody Players, Product Type & Application
  8. 4.5 Global His-Tag Antibody Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global His-Tag Antibody Market CR5 and HHI
  11. 4.6.3 2025 His-Tag Antibody Tier 1, Tier 2, and Tier 3
5 His-Tag Antibody Market Size by Type
  1. 5.1 Global His-Tag Antibody Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global His-Tag Antibody Revenue by Type (2021-2032)
  3. 5.3 Global His-Tag Antibody Revenue Market Share by Type (2021-2032)
6 His-Tag Antibody Market Size by Application
  1. 6.1 Global His-Tag Antibody Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global His-Tag Antibody Revenue by Application (2021-2032)
  3. 6.3 Global His-Tag Antibody Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Aviva Systems Biology
  2. 7.1.1 Aviva Systems Biology Company Information
  3. 7.1.2 Aviva Systems Biology Business Overview
  4. 7.1.3 Aviva Systems Biology His-Tag Antibody Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Aviva Systems Biology His-Tag Antibody Product Portfolio
  6. 7.1.5 Aviva Systems Biology Recent Developments
  7. 7.2 Bio X Cell
  8. 7.2.1 Bio X Cell Company Information
  9. 7.2.2 Bio X Cell Business Overview
  10. 7.2.3 Bio X Cell His-Tag Antibody Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bio X Cell His-Tag Antibody Product Portfolio
  12. 7.2.5 Bio X Cell Recent Developments
  13. 7.3 BioLegend
  14. 7.3.1 BioLegend Company Information
  15. 7.3.2 BioLegend Business Overview
  16. 7.3.3 BioLegend His-Tag Antibody Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BioLegend His-Tag Antibody Product Portfolio
  18. 7.3.5 BioLegend Recent Developments
  19. 7.4 Cell Signaling Technology
  20. 7.4.1 Cell Signaling Technology Company Information
  21. 7.4.2 Cell Signaling Technology Business Overview
  22. 7.4.3 Cell Signaling Technology His-Tag Antibody Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Cell Signaling Technology His-Tag Antibody Product Portfolio
  24. 7.4.5 Cell Signaling Technology Recent Developments
  25. 7.5 Columbia Biosciences
  26. 7.5.1 Columbia Biosciences Company Information
  27. 7.5.2 Columbia Biosciences Business Overview
  28. 7.5.3 Columbia Biosciences His-Tag Antibody Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Columbia Biosciences His-Tag Antibody Product Portfolio
  30. 7.5.5 Columbia Biosciences Recent Developments
  31. 7.6 GeneTex
  32. 7.6.1 GeneTex Company Information
  33. 7.6.2 GeneTex Business Overview
  34. 7.6.3 GeneTex His-Tag Antibody Revenue and Gross Margin (2021-2026)
  35. 7.6.4 GeneTex His-Tag Antibody Product Portfolio
  36. 7.6.5 GeneTex Recent Developments
  37. 7.7 Medimabs
  38. 7.7.1 Medimabs Company Information
  39. 7.7.2 Medimabs Business Overview
  40. 7.7.3 Medimabs His-Tag Antibody Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Medimabs His-Tag Antibody Product Portfolio
  42. 7.7.5 Medimabs Recent Developments
  43. 7.8 NSJ Bioreagents
  44. 7.8.1 NSJ Bioreagents Company Information
  45. 7.8.2 NSJ Bioreagents Business Overview
  46. 7.8.3 NSJ Bioreagents His-Tag Antibody Revenue and Gross Margin (2021-2026)
  47. 7.8.4 NSJ Bioreagents His-Tag Antibody Product Portfolio
  48. 7.8.5 NSJ Bioreagents Recent Developments
  49. 7.9 OriGene
  50. 7.9.1 OriGene Company Information
  51. 7.9.2 OriGene Business Overview
  52. 7.9.3 OriGene His-Tag Antibody Revenue and Gross Margin (2021-2026)
  53. 7.9.4 OriGene His-Tag Antibody Product Portfolio
  54. 7.9.5 OriGene Recent Developments
  55. 7.10 Proteintech
  56. 7.10.1 Proteintech Company Information
  57. 7.10.2 Proteintech Business Overview
  58. 7.10.3 Proteintech His-Tag Antibody Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Proteintech His-Tag Antibody Product Portfolio
  60. 7.10.5 Proteintech Recent Developments
  61. 7.11 Santa Cruz Biotechnology
  62. 7.11.1 Santa Cruz Biotechnology Company Information
  63. 7.11.2 Santa Cruz Biotechnology Business Overview
  64. 7.11.3 Santa Cruz Biotechnology His-Tag Antibody Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Santa Cruz Biotechnology His-Tag Antibody Product Portfolio
  66. 7.11.5 Santa Cruz Biotechnology Recent Developments
  67. 7.12 United States Biological
  68. 7.12.1 United States Biological Company Information
  69. 7.12.2 United States Biological Business Overview
  70. 7.12.3 United States Biological His-Tag Antibody Revenue and Gross Margin (2021-2026)
  71. 7.12.4 United States Biological His-Tag Antibody Product Portfolio
  72. 7.12.5 United States Biological Recent Developments
8 North America
  1. 8.1 North America His-Tag Antibody Revenue (2021-2032)
  2. 8.2 North America His-Tag Antibody Revenue by Type (2021-2032)
  3. 8.2.1 North America His-Tag Antibody Revenue by Type (2021-2026)
  4. 8.2.2 North America His-Tag Antibody Revenue by Type (2027-2032)
  5. 8.3 North America His-Tag Antibody Revenue Share by Type (2021-2032)
  6. 8.4 North America His-Tag Antibody Revenue by Application (2021-2032)
  7. 8.4.1 North America His-Tag Antibody Revenue by Application (2021-2026)
  8. 8.4.2 North America His-Tag Antibody Revenue by Application (2027-2032)
  9. 8.5 North America His-Tag Antibody Revenue Share by Application (2021-2032)
  10. 8.6 North America His-Tag Antibody Revenue by Country
  11. 8.6.1 North America His-Tag Antibody Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America His-Tag Antibody Revenue by Country (2021-2026)
  13. 8.6.3 North America His-Tag Antibody Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe His-Tag Antibody Revenue (2021-2032)
  2. 9.2 Europe His-Tag Antibody Revenue by Type (2021-2032)
  3. 9.2.1 Europe His-Tag Antibody Revenue by Type (2021-2026)
  4. 9.2.2 Europe His-Tag Antibody Revenue by Type (2027-2032)
  5. 9.3 Europe His-Tag Antibody Revenue Share by Type (2021-2032)
  6. 9.4 Europe His-Tag Antibody Revenue by Application (2021-2032)
  7. 9.4.1 Europe His-Tag Antibody Revenue by Application (2021-2026)
  8. 9.4.2 Europe His-Tag Antibody Revenue by Application (2027-2032)
  9. 9.5 Europe His-Tag Antibody Revenue Share by Application (2021-2032)
  10. 9.6 Europe His-Tag Antibody Revenue by Country
  11. 9.6.1 Europe His-Tag Antibody Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe His-Tag Antibody Revenue by Country (2021-2026)
  13. 9.6.3 Europe His-Tag Antibody Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China His-Tag Antibody Revenue (2021-2032)
  2. 10.2 China His-Tag Antibody Revenue by Type (2021-2032)
  3. 10.2.1 China His-Tag Antibody Revenue by Type (2021-2026)
  4. 10.2.2 China His-Tag Antibody Revenue by Type (2027-2032)
  5. 10.3 China His-Tag Antibody Revenue Share by Type (2021-2032)
  6. 10.4 China His-Tag Antibody Revenue by Application (2021-2032)
  7. 10.4.1 China His-Tag Antibody Revenue by Application (2021-2026)
  8. 10.4.2 China His-Tag Antibody Revenue by Application (2027-2032)
  9. 10.5 China His-Tag Antibody Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia His-Tag Antibody Revenue (2021-2032)
  2. 11.2 Asia His-Tag Antibody Revenue by Type (2021-2032)
  3. 11.2.1 Asia His-Tag Antibody Revenue by Type (2021-2026)
  4. 11.2.2 Asia His-Tag Antibody Revenue by Type (2027-2032)
  5. 11.3 Asia His-Tag Antibody Revenue Share by Type (2021-2032)
  6. 11.4 Asia His-Tag Antibody Revenue by Application (2021-2032)
  7. 11.4.1 Asia His-Tag Antibody Revenue by Application (2021-2026)
  8. 11.4.2 Asia His-Tag Antibody Revenue by Application (2027-2032)
  9. 11.5 Asia His-Tag Antibody Revenue Share by Application (2021-2032)
  10. 11.6 Asia His-Tag Antibody Revenue by Country
  11. 11.6.1 Asia His-Tag Antibody Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia His-Tag Antibody Revenue by Country (2021-2026)
  13. 11.6.3 Asia His-Tag Antibody Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA His-Tag Antibody Revenue (2021-2032)
  2. 12.2 SAMEA His-Tag Antibody Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA His-Tag Antibody Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA His-Tag Antibody Revenue by Type (2027-2032)
  5. 12.3 SAMEA His-Tag Antibody Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA His-Tag Antibody Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA His-Tag Antibody Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA His-Tag Antibody Revenue by Application (2027-2032)
  9. 12.5 SAMEA His-Tag Antibody Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA His-Tag Antibody Revenue by Country
  11. 12.6.1 SAMEA His-Tag Antibody Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA His-Tag Antibody Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA His-Tag Antibody Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst